<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://new.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 14 Aug 2026 08:55:33 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://new.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>LENSAR Inc. (LNSR) PT Raised to $13 at Lake Street</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/LENSAR+Inc.+%28LNSR%29+PT+Raised+to+%2413+at+Lake+Street/26925404.html</link>
   <description>Lake Street analyst Frank Takkinen raised the price target on LENSAR Inc. (NASDAQ: LNSR) to $13.00  (from $10.00) while maintaining a Buy rating.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/LENSAR+Inc.+%28LNSR%29+PT+Raised+to+%2413+at+Lake+Street/26925404.html</guid>
   <pubDate>Fri, 14 Aug 2026 08:55:33 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	  </item>
  <item>
   <title>Form  10-Q       LENSAR, Inc.              For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LENSAR%2C+Inc.++++++++++++++For%3A+Jun+30/26921911.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26921911.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LENSAR%2C+Inc.++++++++++++++For%3A+Jun+30/26921911.html</guid>
   <pubDate>Thu, 13 Aug 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>Form  10-Q       LENSAR, Inc.              For: Jun 30</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LENSAR%2C+Inc.++++++++++++++For%3A+Jun+30/26921911.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26921911.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++LENSAR%2C+Inc.++++++++++++++For%3A+Jun+30/26921911.html</guid>
   <pubDate>Thu, 13 Aug 2026 16:32:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>LENSAR Inc. (LNSR) PT Raised to $9 at BTIG</title>
   <link>http://www.streetinsider.com/Analyst+PT+Change/LENSAR+Inc.+%28LNSR%29+PT+Raised+to+%249+at+BTIG/26918970.html</link>
   <description>&lt;p&gt;BTIG analyst Ryan Zimmerman raised the price target on LENSAR Inc. (NASDAQ: LNSR) to $9.00 (from $7.00) while maintaining a Buy rating.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Analyst+PT+Change/LENSAR+Inc.+%28LNSR%29+PT+Raised+to+%249+at+BTIG/26918970.html</guid>
   <pubDate>Thu, 13 Aug 2026 12:10:37 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	  </item>
  <item>
   <title>Form  8-K        LENSAR, Inc.              For: Aug 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+13/26916343.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26916343.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+13/26916343.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>Form  8-K        LENSAR, Inc.              For: Aug 13</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+13/26916343.html</link>
   <description>si-local-file:///var/storage/secattach/20260813/26916343.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+13/26916343.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:10:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>LENSAR, Inc. (LNSR) Tops Q2 EPS by 31c</title>
   <link>http://www.streetinsider.com/Earnings/LENSAR%2C+Inc.+%28LNSR%29+Tops+Q2+EPS+by+31c/26916314.html</link>
   <description>&lt;p&gt;LENSAR, Inc. (NASDAQ: LNSR) reported Q2 EPS of $0.10, $0.31 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $15 million.&lt;/p&gt;&lt;p&gt;For earnings history and earnings-related data on LENSAR, Inc. (LNSR) &lt;a href=&quot;http://www.streetinsider.com/ec_earnings.php?q=LNSR&quot;&gt;click here&lt;/a&gt;.&lt;/p&gt;</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Earnings/LENSAR%2C+Inc.+%28LNSR%29+Tops+Q2+EPS+by+31c/26916314.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:07:15 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>LENSAR® Reports Second Quarter 2026 Results and Provides Business Update</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;10 ALLY Robotic Cataract Laser Systems® (“ALLY System”) Placements in Second Quarter 2026; Backlog of 13 ALLY Systems as of June 30, 2026&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Second Quarter Recurring Revenue was $13.7 million&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Total Laser Installed Base Climbs to 445 Systems, Driven by 30% Growth in ALLY Placements&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;ORLANDO, Fla., Aug.  13, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced financial results for the quarter ended June 30, 2026 and provided an update on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+Reports+Second+Quarter+2026+Results+and+Provides+Business+Update/26916196.html</guid>
   <pubDate>Thu, 13 Aug 2026 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.14797296</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">A.38865800</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00097061</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.14656421</category>
   	  </item>
  <item>
   <title>Form  8-K        LENSAR, Inc.              For: Aug 04</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+04/26897765.html</link>
   <description>si-local-file:///var/storage/secattach/20260810/26897765.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+04/26897765.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>Form  8-K        LENSAR, Inc.              For: Aug 04</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+04/26897765.html</link>
   <description>si-local-file:///var/storage/secattach/20260810/26897765.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++LENSAR%2C+Inc.++++++++++++++For%3A+Aug+04/26897765.html</guid>
   <pubDate>Mon, 10 Aug 2026 16:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026</title>
   <link>http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+to+Report+Second+Quarter+2026+Results+on+August+13th%2C+2026/26879076.html</link>
   <description>&lt;p style=&quot;padding-left:0pt;&quot;&gt;ORLANDO, Fla., Aug.  06, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 13, 2026 to discuss the results, recent corporate and operational highlights and provide an update on key strategic initiatives.&lt;/p&gt;  &lt;p style=&quot;padding-left:0pt;&quot;&gt;To participate by telephone, please use this</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/LENSAR%C2%AE+to+Report+Second+Quarter+2026+Results+on+August+13th%2C+2026/26879076.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	  </item>
  <item>
   <title>LENSAR® to Report Second Quarter 2026 Results on August 13th, 2026</title>
   <link>http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+to+Report+Second+Quarter+2026+Results+on+August+13th%2C+2026/26879076.html</link>
   <description>&lt;p style=&quot;padding-left:0pt;&quot;&gt;ORLANDO, Fla., Aug.  06, 2026  (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, today announced that the Company’s second quarter 2026 financial results will be released before market open on Thursday, August 13, 2026. LENSAR’s management will host a conference call and webcast at 8:30 am ET on Thursday, August 13, 2026 to discuss the results, recent corporate and operational highlights and provide an update on key strategic initiatives.&lt;/p&gt;  &lt;p style=&quot;padding-left:0pt;&quot;&gt;To participate by telephone, please use this</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/LENSAR%C2%AE+to+Report+Second+Quarter+2026+Results+on+August+13th%2C+2026/26879076.html</guid>
   <pubDate>Thu, 06 Aug 2026 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  LENSAR, Inc.                           Filed by: BlackRock, Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++LENSAR%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834323.html</link>
   <description>si-local-file:///var/storage/secattach/20260729/26834323.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++LENSAR%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834323.html</guid>
   <pubDate>Wed, 29 Jul 2026 15:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
  <item>
   <title>Form  SCHEDULE 13G/A  LENSAR, Inc.                           Filed by: BlackRock, Inc.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++LENSAR%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834323.html</link>
   <description>si-local-file:///var/storage/secattach/20260729/26834323.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++LENSAR%2C+Inc.+++++++++++++++++++++++++++Filed+by%3A+BlackRock%2C+Inc./26834323.html</guid>
   <pubDate>Wed, 29 Jul 2026 15:21:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">LNSR</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.06674946</category>
   	  </item>
 </channel>
</rss>
